Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hirsch

Showing results (441-450 of 686) with videos related to

Pageof 69
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2026
Prospective Cohort Study Evaluating Impact of Hemodialysis on Glycemia: BLOSSOM (Blood Sugar Sensing on Maintenance Dialysis) Cohort FindingsYoshio N Hall, Leila R Zelnick, Irl B Hirsch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Significant publications on infectious diseases pharmacotherapy in 2009Hannah R Palmer, Jessica M Cottreau, Kevin W Garey, et al.
Diabetes Care|March 1, 2005
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSIIIrl B Hirsch, Bruce W Bode, Satish Garg, et al.
The Journal of Clinical Investigation|August 6, 1998
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodentsA Wiersma, B Hirsch, A Tsafriri, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2024
Development and implementation of the ASHP Midyear Travel Award to support racially and ethnically minoritized pharmacy studentsJacinda C Abdul-Mutakabbir, Ila M Saunders, Aiman Bandali, et al.
The Lancet. Diabetes & Endocrinology|July 22, 2022
Blood glucose targets in the critically ill: is one size fits all still appropriate?James S Krinsley, Michael Brownlee, Michael W Schwartz, et al.
Journal of Critical Care|September 15, 2023
Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemiaGreg Roberts, James S Krinsley, Jean-Charles Preiser, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: A patient-level analysis of published dataJ Nicholas O'Donnell, Nathaniel J Rhodes, Lauren R Biehle, et al.
BMJ Open Diabetes Research & Care|March 13, 2018
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)Sofia Dahlqvist, Elsa Ahlén, Karin Filipsson, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 29, 2014
An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing EnterobacteriaceaeElizabeth B Hirsch, Kai-Tai Chang, Paola C Zucchi, et al.
Pageof 69

Showing results (441-450 of 686) with videos related to

Sort By:
Pageof 69
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2026
Prospective Cohort Study Evaluating Impact of Hemodialysis on Glycemia: BLOSSOM (Blood Sugar Sensing on Maintenance Dialysis) Cohort FindingsYoshio N Hall, Leila R Zelnick, Irl B Hirsch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Significant publications on infectious diseases pharmacotherapy in 2009Hannah R Palmer, Jessica M Cottreau, Kevin W Garey, et al.
Diabetes Care|March 1, 2005
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSIIIrl B Hirsch, Bruce W Bode, Satish Garg, et al.
The Journal of Clinical Investigation|August 6, 1998
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodentsA Wiersma, B Hirsch, A Tsafriri, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2024
Development and implementation of the ASHP Midyear Travel Award to support racially and ethnically minoritized pharmacy studentsJacinda C Abdul-Mutakabbir, Ila M Saunders, Aiman Bandali, et al.
The Lancet. Diabetes & Endocrinology|July 22, 2022
Blood glucose targets in the critically ill: is one size fits all still appropriate?James S Krinsley, Michael Brownlee, Michael W Schwartz, et al.
Journal of Critical Care|September 15, 2023
Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemiaGreg Roberts, James S Krinsley, Jean-Charles Preiser, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: A patient-level analysis of published dataJ Nicholas O'Donnell, Nathaniel J Rhodes, Lauren R Biehle, et al.
BMJ Open Diabetes Research & Care|March 13, 2018
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)Sofia Dahlqvist, Elsa Ahlén, Karin Filipsson, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 29, 2014
An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing EnterobacteriaceaeElizabeth B Hirsch, Kai-Tai Chang, Paola C Zucchi, et al.
Pageof 69